March 16, 2015 by Jeffrey Woldt and Chain Drug Review
Affordable Care Act, Department of Health and Human Services, health care reform, health care spending, HealthCare.gov, Jeffrey Woldt, King v. Burwell
2015, Issue 03-16-2015, Opinion
Although the Affordable Care Act was signed into law by President Obama five years ago and the major provisions of the legislation took effect at the beginning of 2014, health care reform remains a highly contentious work in progress. Two recent reports provide some indications about the ACA’s success to date in achieving its primary
February 16, 2015 by Jeffrey Woldt and Chain Drug Review
Ahold USA, Amy Hahn, CVS/pharmacy, Delhaize America, Food Lion, Food Marketing Institute, Helena Foulkes, Indra Nooyi, Irene Rosenfeld, Jeffrey Woldt, Joan Toth, Judy Sansone, Karen Fondu, Kathee Tesija, L’Oréal Paris, Meg Ham, Michelle Gloeckler, Mondelez International, Network of Executive Women, PepsiCo, retail industry, Target, Walmart
Issue 02-16-2015, Opinion
Many of the boldface names in the retail and consumer products sectors belong to women. Helena Foulkes is president of CVS/pharmacy, the drug chain where Judy Sansone is chief merchant. Kathee Tesija holds the latter position at Target, and Michelle Gloeckler runs Walmart’s consumables business and heads up the company’s U.S. Manufacturing initiative. Delhaize America
February 2, 2015 by Jeffrey Woldt and Chain Drug Review
Bartell Drugs, Bartell family, Canadian operations, chain drug industry, CVS Health, Dollar Tree, Family Dollar, Fred's, Jeffrey Woldt, Mike Bloom, NACDS, National Association of Chain Drug Stores, RediClinic, retail pharmacy, Rite Aid, RxImpact Day, Target, Walgreens Boots Alliance, Walmart
2015, Issue 02-02-2015, Opinion
The new year is just over a month old and already the chain drug industry has seen its fair share of noteworthy events. Walgreens Boots Alliance had a coming out party, opening trading at NASDAQ and unveiling its new corporate logo; Brian Unmacht became the first person outside the Bartell family to serve as president
January 19, 2015 by Jeffrey Woldt and Chain Drug Review
Affordable Care Act, biotechnology, community pharmacy, CVS Health, health care system, Jeffrey Woldt, Kroger, National Association of Chain Drug Stores, pharmaceuticals, pharmacists, pharmacy operators, pharmacy practice, Rite Aid, Walgreen, Walgreens Boots Alliance, Walmart
2015, Issue 01-19-2015, Opinion
In the not-too-distant past community pharmacy was correctly perceived as a conservative business whose members were intent on operating within a well-defined set of parameters and not rocking the boat. A generation ago it wasn’t uncommon to hear members of the profession joke about what they did as “lick, stick and pour.” The industry as
January 5, 2015 by Jeffrey Woldt and Chain Drug Review
Alliance Boots, Chain Drug Review, Greg Wasson, Kermit Crawford, Ronald L. Ziegler Lifetime Achievement Award, Walgreens
2015, Issue 01-05-2015, News
DEERFIELD, Ill. — Kermit Crawford, who retired as Walgreen Co.’s president of pharmacy, health and wellness on December 31, ended his career at Walgreens the same way he began it 31 years ago — providing the best in patient care. Building on the ethos instilled in him by his mother, Doris Crawford, while he was
January 5, 2015 by Jeffrey Woldt and Chain Drug Review
Alliance Boots, CEO, chief executive officer, drug chain, Greg Wasson, Jeffrey Woldt, retail pharmacy, Stefano Pessina, Walgreens
2015, Issue 01-05-2015, Opinion
When the history of Walgreen Co. is written, Greg Wasson, who last month announced that he would step down as chief executive officer of the drug chain upon completion of its merger with Alliance Boots, will be seen as one of the company’s most consequential leaders. A product of the Walgreens system who joined the